Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluocinolone Acetonide
Therapeutic Area : Ophthalmology
Study Phase : Approved
Sponsor : Alimera Sciences
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, Alimera and Horus have agreed to increase the commercialization efforts for ILUVIEN (fluocinolone acetonide) for both diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in Euro...
Brand Name : Iluvien
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 03, 2023
Lead Product(s) : Fluocinolone Acetonide
Therapeutic Area : Ophthalmology
Highest Development Status : Approved
Sponsor : Alimera Sciences
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?